Results 11 to 20 of about 3,843,014 (290)

Left Ventricular Assist Device Support Complicates the Exercise Physiology of Oxygen Transport and Uptake in Heart Failure [PDF]

Cardiac Failure Review, 2019
Low-output forward flow and impaired maximal exercise oxygen uptake (VO2 max) are hallmarks of patients in advanced heart failure. The continuous-flow left ventricular assist device is a cutting-edge therapy proven to increase forward flow, yet this ...
Erik H Van Iterson
doaj   +2 more sources

Echocardiography in left ventricular assist device

Heart Views, 2010
LVAD = Left Ventricular Assist Device; LV = Left Ventricle; LA = Left Atrium; AO = Aorta.
Sherif M Helmy, Alia Albinali, Rachel Hajar   +2 more
doaj   +3 more sources

Experience with left ventricular assist device usage in the treatment of end-stage heart failure [PDF]

Кардіохірургія та інтервенційна кардіологія, 2017
Heart failure potentially developing in most of heart diseases is a progressive process associated with high morbidity and mortality. Almost 3/4 of patients die within five years after first hospitalization because of heart failure.
B.M. Todurov, G.I. Kovtun, I.M. Kuzmich, M.V. Goncharenko, A.M. Druzhyna, A.O. Shpachuk, O.M. Postupalsky, S.O. Sheludko, S.M. Sudakevych, O.V. Stanyshevskyi, A.Yu. Melnyk   +10 more
doaj   +1 more source

Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundVasoplegia is associated with adverse outcomes following cardiac surgery; however, its impact following left ventricular assist device implantation is largely unexplored.
Kristen M. Tecson, Brian Lima, Andy Y. Lee, Fayez S. Raza, Grace Ching, Cheng‐Han Lee, Joost Felius, Ronald D. Baxter, Sasha Still, Justin D. G. Collier, Shelley A. Hall, Susan M. Joseph   +11 more
doaj   +3 more sources

Left Ventricular Assist Devices [PDF]

Health Affairs, 2015
The left ventricular assist device (LVAD) has become an established treatment option for patients with refractory heart failure. Many of these patients experience chronic kidney disease (CKD) due to chronic cardiorenal syndrome type II, which is often alleviated quickly following LVAD implantation.
Kory Lavine, Susan Joseph
  +7 more sources

Lumped-Parameter Modelling of Cardiovascular System Dynamics under Different Healthy and Diseased Conditions [PDF]

, 2013
Cardiovascular disease is the most common cause of death in the modern society, and research into the diagnosis and treatment of cardiovascular diseases is an urgent task.
Shi, Yubing
core   +6 more sources

Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims The continuous flow left ventricular assist device (cf-LVAD) has improved the survival of chronic end-stage heart failure (HF) patients.
Yoonjee Park, Darae Kim, Jeong Hoon Yang, Yang Hyun Cho, Jin-Oh Choi, Eun-Seok Jeon   +5 more
doaj   +1 more source

Percutaneous left ventricular assist devices in refractory cardiac arrest: The role of chest compressions

Resuscitation Plus, 2023
Background: Recent studies describe an emerging role for percutaneous left ventricular assist devices such as Impella CP® as rescue therapy for refractory cardiac arrest.
Adam L. Gottula, Brendan M. McCracken, Takahiro Nakashima, Nicholas L. Greer, Traci A. Cramer, Nadia R. Sutton, Kevin R. Ward, Robert W. Neumar, Mohamad Hakam Tiba, Cindy H. Hsu   +9 more
doaj   +1 more source

Study of a bi-directional axial flow blood pump [PDF]

, 2012
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel University.A common treatment for circulatory disorders is the application of rotary blood pumps to locally increase blood flow to required levels.
Swalen, Marcel Johannes Petrus
core   +7 more sources

Right and left ventricular assist devices are an option for bridge to heart transplantCentral MessagePerspective

JTCVS Open, 2022
Background: Patients with a left ventricular assist device with right ventricular failure are prioritized on the heart transplant waitlist; however, their post-transplant survival is less well characterized.
Yaron D. Barac, MD, PhD, Ronen Toledano, MD, Oliver K. Jawitz, MD, Jacob N. Schroder, MD, Mani A. Daneshmand, MD, Chetan B. Patel, MD, Dan Aravot, MD, Carmelo A. Milano, MD   +7 more
doaj   +1 more source